Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis

Published:2021-02-03 Issue: Volume: Page:
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Ferraro Claire F.¹²^ORCID,Stewart Daniel E.¹²^ORCID,Grebely Jason³^ORCID,Tran Lucy T.⁴,Zhou Shally⁴,Puca Carla⁴,Hajarizadeh Behzad³^ORCID,Larney Sarah⁴⁵^ORCID,Santo Thomas⁴^ORCID,Higgins Julian P. T.¹^ORCID,Vickerman Peter¹^ORCID,Degenhardt Louisa⁴^ORCID,Hickman Matthew¹^ORCID,French Clare E.¹^ORCID

Affiliation:

1. Health Protection Research Unit, Population Health Sciences University of Bristol Canynge Hall, 39 Whatley Road, Clifton Bristol BS8 2PS UK

2. National Public Health Speciality Training Programme, South West Bristol UK

3. Kirby Institute, University of South Wales Sydney Sydney Australia

4. National Drug and Alcohol Research Centre University of South Wales Sydney, Sydney, Australia

5. Department of Family Medicine and Emergency Medicine Université de Montréal and Research Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM) Quebec Canada

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15316

Reference49 articles.

1. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

2. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease study 2013;Degenhardt L.;Lancet Infect Dis,2016

3. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study

4. Joint United Nations Programme on HIV and AIDS (UNAIDS).Health Rights and Drugs: Harm Reduction Decriminalization and Zero Discrimination for People who Use Drugs2019. Available at:https://www.unaids.org/en/resources/documents/2019/JC2954_UNAIDS_drugs_report_2019(accessed 3 March 2020).

5. WHO ‘Treatment as Prevention’ guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Past-Year HIV Testing, Current Antiretroviral Therapy Use, and Participation in Services for People Who Inject Drugs;AIDS and Behavior;2024-06-01

2. Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland;Harm Reduction Journal;2024-05-08

3. Opioid Agonist Maintenance Treatment Outcomes—The OPTIMUS International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report;International Journal of Mental Health and Addiction;2023-12-26

4. Past-year HIV testing, current antiretroviral therapy use, and participation in services for people who inject drugs;2023-10-25

5. Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study;International Journal of Drug Policy;2023-06